Company’s broad spectrum parasiticide on-track for October U.S. approval and first quarter 2025 launch GREENFIELD, Ind., Aug. 20, 2024 /PRNewswire/ — Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has completed its review of all…